Governance frameworks for COVID-19 research ethics review and oversight in Latin America : an exploratory study [Separata] /

Background: Research has been an essential part of the COVID-19 pandemic response, including in Latin American (LA) countries. However, implementing research in emergency settings poses the challenge of producing valuable knowledge rapidly while upholding research ethical standards. Research ethics...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bianchini, Alahí Dana (Autor), Palmero, Ana (Autor), Carracedo, Sarah (Autor), Cabrera, Noelia (Autor)
Autor Corporativo: FLACSO. Programa Argentina
Formato: Libro
Lenguaje:Español
Inglés
Materias:
Acceso en línea:https://doi.org/10.1186/s12910-021-00715-2
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 03540nam a22003977a 4500
003 AR-BaFLA
005 20240814154113.0
008 240729t2021 ag ||||fs|||| 00| 0 spa d
037 |n Depósito reglamentario 
040 |a AR-BaFLA  |c AR-BaFLA  |b spa  |e rda 
041 0 |a eng 
043 |c XL 
100 1 |9 33577  |a Bianchini, Alahí Dana  |e aut. 
110 2 |a FLACSO. Programa Argentina  |9 110 
245 1 0 |a Governance frameworks for COVID-19 research ethics review and oversight in Latin America :   |b an exploratory study [Separata] /   |c Ana Palmero, Sarah Carracedo , Noelia Cabrera and Alahí Bianchini  |h DIG 
300 |a 9 p. 
336 |2 rdacontent  |a Texto  |b txt 
337 |2 rdamedia  |a computadora  |b c 
338 |2 rdacarrier  |a Recurso el línea  |b cr 
504 |a incl. ref. 
520 |a Background: Research has been an essential part of the COVID-19 pandemic response, including in Latin American (LA) countries. However, implementing research in emergency settings poses the challenge of producing valuable knowledge rapidly while upholding research ethical standards. Research ethics committees (RECs) therefore must conduct timely and rigorous ethics reviews and oversight of COVID-19 research. In the LA region, there is limited knowledge on how countries have responded to this need. To address this gap, the objective of our project is to explore if LA countries developed policies to streamline ethics review and oversight of research in response to the pandemic while ensuring its adherence to ethical standards, and to analyze to what extent these governance frameworks are in accordance with international guidance. Methods: We conducted a descriptive and exploratory study assessing the COVID-19 research ethics governance frameworks of 19 LA countries, considering 4 dimensions based on international COVID-19 ethics guidance documents: (i) ethics review organizational model adopted, (ii) measures to coordinate between RECs and other research stakeholders, (iii) operational guidance for RECs, and (iv) key ethical issues for review and oversight of COVID-19 research. Results: 10 out of 19 LA countries have some policy to streamline ethics review of COVID-19 research. Of these countries only 6 issued comprehensive documents following international guidance that contemplate strategies with recommendations for concrete actions for a timely and rigorous review. Conclusion: LA countries adopted partial strategies and operational guidance that may demonstrate a lack of a comprehensive view of research ethics for the review and oversight of COVID-19 research. Continuing eforts should be directed to strengthen LA countries’ research capacity to respond timely and ethically to future health emergencies. Past lessons and the ones from this pandemic should be the basis to develop international standards and operational guidelines for ethics review and oversight of any research for public health emergencies. 
650 4 |a PANDEMIA  |9 11878 
650 4 |a  INVESTIGACION MEDICA  |9 2776 
650 4 |a TRATAMIENTO DE ENFERMEDADES  |9 10193 
650 4 |a ETICA MEDICA  |9 10121 
650 4 |a POLITICA DE SALUD  |9 651 
650 0 |a EPIDEMIAS  |9 6815 
651 4 |a AMERICA LATINA  |9 164 
690 |a BIOETICA 
700 1 |a Palmero, Ana  |9 38945  |e aut. 
700 1 |a Carracedo, Sarah  |9 38946  |e aut. 
700 1 |a Cabrera, Noelia  |9 28152  |e aut. 
773 |d London : BioMed Central , 2023  |t BMC medical ethics  |g Vol. 22 no. 147  |x 1472-6939 
856 |u https://doi.org/10.1186/s12910-021-00715-2 
942 |c ART 
999 |c 51508  |d 51508